About-cancer/screening/research/zh

篩選研究

肺癌篩查後，後續程序可能比想像中要冒險

發表於：二月8，2019

在日常醫療保健中，肺癌篩查後進行的侵入性診斷程序可能比大型研究報告的併發症更多。

關鍵數字：癌症篩查統計真正告訴我們的是什麼

更新時間：2018年7月16日

癌症篩查研究表明，更多的篩查不一定意味着更少的癌症死亡。 本文介紹了如何解釋用於描述篩選研究結果的統計數據。

互動應用程序可提高大腸癌篩查率

發表於：四月9，2018

結腸直腸癌篩查可減少因疾病而導致的死亡，但約有三分之一的美國人尚未進行篩查。 了解當等待例行檢查的人們使用允許他們訂購自己的篩查測試的應用時發生了什麼。

為了預防遺傳性癌症，研究人員專注於林奇綜合症

更新日期：2017年8月8日

在NCI主持的研討會上，專家們討論了與使用Lynch綜合徵作為預防遺傳性癌症的模型有關的問題。

NCI研究表明Li-Fraumeni綜合徵患者進行癌症篩查方案的可行性

發表於：八月3，2017

NCI的一項新研究表明，針對Li-Fraumeni綜合徵（一種罕見的遺傳性疾病，導致罹患某些癌症的風險更高）進行全面篩查的可行性。

In an Era of Precision Medicine, Testing New Approaches to Breast Cancer Screening

Posted: May 9, 2017

Researchers are testing individualized approaches that could identify those at risk of breast cancer who need to be screened and testing screening intervals that are appropriate for each person’s level of risk.

==

Lung Cancer Screening Pilot Reveals Challenges, Growing Pains ====

Posted: February 27, 2017

A demonstration project by the Veterans Health Administration is highlighting some of the complexities and challenges associated with the expansion of lung cancer screening in the United States.

Enhanced Risk-Based Lung Cancer Screening May Prevent More Deaths than Current Approaches

Posted: June 2, 2016

A blog post on a modeling study from NCI researchers suggesting that individualized, risk-based selection of ever-smokers for lung cancer screening may prevent more lung cancer deaths compared with current screening recommendations.

Bringing Precision to Screening for Cancer

Posted: November 17, 2015

A recent NCI-sponsored conference brought together leading screening and cancer control researchers to discuss the state of the science of precision screening for five cancers.

Overdiagnosis of Cancer: Bringing an Important Problem into Focus

Posted: August 28, 2015

Experts are convening for a conference on the dilemmas posed by overdiagnosis in many types of diseases. Overdiagnosis is generally defined as the diagnosis of a disease or condition that is unlikely to ever cause harm.

Screening Rates for Several Cancers Miss Their Targets

Posted: May 26, 2015

Screening rates for breast, colorectal, and cervical cancer are lagging behind target rates set by the Healthy People 2020 program, according to a new study.

NIH study finds negative HPV screening test result is a better predictor of low cervical cancer risk than a negative Pap test

Posted: July 18, 2014

Based on a study that included more than 1 million women, investigators at NCI have determined that a negative test for HPV infection compared to a negative Pap test provides greater safety, or assurance, against future risk of cervical cancer.